CTNNBIP1

catenin beta interacting protein 1

Basic information

Region (hg38): 1:9848276-9910336

Links

ENSG00000178585NCBI:56998OMIM:607758HGNC:16913Uniprot:Q9NSA3AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CTNNBIP1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CTNNBIP1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
1
clinvar
1
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 1 0 0

Variants in CTNNBIP1

This is a list of pathogenic ClinVar variants found in the CTNNBIP1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-9871204-G-A not specified Uncertain significance (May 23, 2024)3270138
1-9871229-T-C not specified Uncertain significance (May 26, 2022)2291378
1-9871231-A-C not specified Uncertain significance (Aug 19, 2024)3498343

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CTNNBIP1protein_codingprotein_codingENST00000377263 362061
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.02480.793125742061257480.0000239
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5294353.90.7970.00000370516
Missense in Polyphen1716.7941.0123170
Synonymous-1.062720.81.300.00000153150
Loss of Function0.99135.510.5444.19e-747

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.00009920.0000992
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00003530.0000352
Middle Eastern0.000.00
South Asian0.000.00
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Prevents the interaction between CTNNB1 and TCF family members, and acts as negative regulator of the Wnt signaling pathway. {ECO:0000269|PubMed:12408824}.;
Pathway
Wnt signaling pathway - Homo sapiens (human);Wnt Signaling Pathway;Signaling by WNT;Signal Transduction;Deactivation of the beta-catenin transactivating complex;Wnt Canonical;Regulation of nuclear beta catenin signaling and target gene transcription;TCF dependent signaling in response to WNT;Wnt Mammals (Consensus)

Intolerance Scores

loftool
0.459
rvis_EVS
0.37
rvis_percentile_EVS
74.95

Haploinsufficiency Scores

pHI
0.219
hipred
Y
hipred_score
0.719
ghis
0.448

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.448

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ctnnbip1
Phenotype
growth/size/body region phenotype; cellular phenotype; craniofacial phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; embryo phenotype; renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype;

Gene ontology

Biological process
branching involved in ureteric bud morphogenesis;regulation of vascular permeability involved in acute inflammatory response;anterior/posterior pattern specification;Wnt signaling pathway;negative regulation of Wnt signaling pathway;negative regulation of protein binding;negative regulation of DNA binding;negative regulation of DNA-binding transcription factor activity;positive regulation of monocyte differentiation;positive regulation of osteoblast differentiation;negative regulation of smooth muscle cell proliferation;negative regulation of transcription initiation from RNA polymerase II promoter;negative regulation of mesenchymal cell proliferation
Cellular component
nucleus;nucleoplasm;cytoplasm;cytosol;beta-catenin destruction complex
Molecular function
protein binding;beta-catenin binding;armadillo repeat domain binding